Skip to main content
. 2016 Nov 15;7(19):534–546. doi: 10.4239/wjd.v7.i19.534

Table 1.

Body weight and plasma biochemical parameters of the placebo-treated and linagliptin-treated db/db mice at the 10th, 14th and 18th week of age

Parameters Placebo group (n = 8)
Linagliptin group (n = 8)
10 wk 14 wk 18 wk 10 wk 14 wk 18 wk
Body weight, g 35.1 (25.6-47.7) 33.2 (24.6-50.9) 37.3 (27.3-51.6) 37.6 (34.5-44.2) 39.9 (30.0-42.3) 41.7 (31.5-45.0)
Glucose, mg/dL 637 (549-678) 579 (551-671) 610 (506-683) 651 (631-693) 588 (520-640) 625 (601-646)
Triglycerides, mg/dL 415 (209-510) 324 (209-336) 316 (149-555) 385 (262-637) 279 (251-315) 391 (238-480)
Total cholesterol, mg/dL 129 (94-156) 100 (39-140) 131 (22-156) 112 (28-132) 104 (24-124) 71 (18-120)
ALT, U/L 132 (105-375) 126 (72-369) 170 (69-306) 146 (84-255) 185 (118-225) 203 (80-294)
GGT, U/L 16.7 (8.2-28.1) 13 (8.5-25.1) 14.6 (10.5-16.5) 14.4 (8.9-18.7) 12.5 (7.1-22) 13.6 (10.5-22.7)

Data are shown as the medians, minimal and maximal values. No significant differences in the variables in both groups at week 10 and 18 (Wilcoxon signed rank test, all P > 0.05). The differences between groups are not significant at week 10, 14 and 18 (U-test, all P > 0.05). ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transpeptidase.